Intravitreal Ranibizumab Therapy for Choroidal Neovascularization Secondary to Pathological Myopia: 3 Year Outcome
INTRODUCTION[|]The purpose of this study is to report our functional and anatomical results of intravitreal ranibizumab (IVR) for choroidal neovascularization secondary to pathological myopia (mCNV).[¤]METHODS[|]In this retrospective study, 32 mCNV patients' 32 eyes were evaluated. After one IV...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
KARE Publishing
2018-04-01
|
| Series: | Beyoglu Eye Journal |
| Subjects: | |
| Online Access: | https://jag.journalagent.com/z4/download_fulltext.asp?pdir=beyoglu&un=BEJ-88598 |